Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) – Equities research analysts at Litchfield Hills Research issued their FY2023 EPS estimates for Adial Pharmaceuticals in a report released on Monday, April 3rd. Litchfield Hills Research analyst T. O’neill anticipates that the company will earn ($0.49) per share for the year. The consensus estimate for Adial Pharmaceuticals’ […]
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Get Rating) was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 542,700 shares, an increase of 42.2% from the February 28th total of 381,600 shares. Based on an average daily trading volume, of 720,700 shares, […]
Geode Capital Management LLC Buys 10,261 Shares of Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Dr. Bankole Johnson Continues Partnership With Exclusive Haute MD Network
Share Article
Medical Sanctuary Expert From Miami/Fort Lauderdale, Dr. Bankole Johnson, continues his partnership with Haute MD Network, now in his second year.
Professor Johnson has served as Editor-in-Chief and on the Editorial Boards of prestigious medical journals and reviewed more than 30 journals in pharmacology, neuroscience, and addictions. MIAMI (PRWEB) March 09, 2021 Professor Bankole A. Johnson, D.Sc., M.D., MBChB, MPhil, FRCPsych, DFAPA, Dip-ABAM, Dip-ABDA, FACFEI
Professor Johnson (2013 – 2019) served as The Dr. Irving J. Taylor Professor and Chair in the Department of Psychiatry, and Professor of Anatomy & Neurobiology, Medicine, Neurology, and Pharmacology at the University of Maryland School of Medicine. He directs all brain sciences across multiple departments at the School under the aegis of the Brain Science Research